Stephana Eilene Patton

General Counsel, Lineage Cell Therapeutics.

Companies

CUTERA INCGeneral counsel Nov 17, 2023 to Feb 21, 2025¹
Eiger BioPharmaceuticals, Inc.Officer Mar 25, 2019 to Mar 15, 2021²
Lineage Cell TherapeuticsGeneral counsel Feb 15, 2017 to Dec 20, 2018³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

CUTERA INC77,216 shares⁴Feb 13, 2025

As of each latest filing. The line shows shares held over time.

Recent filings

Feb 13, 2025Shares withheld for tax 623 shares at $0.42 of CUTERA INC⁴
Nov 13, 2024Shares withheld for tax 2,161 shares at $0.36 of CUTERA INC⁵
Mar 6, 2024Granted 30,000 shares of CUTERA INC⁶
Mar 6, 2024Granted 25,000 shares of CUTERA INC⁶
Mar 6, 2024Granted 25,000 shares of CUTERA INC⁶

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARCUTERA INC, General counsel
2
SEC EDGAREiger BioPharmaceuticals, Inc., Officer
3
SEC EDGARLineage Cell Therapeutics, General counsel
4
SEC EDGARCUTERA INC shares after the filing of Feb 13, 2025
5
SEC EDGARForm 4 filed Nov 15, 2024
6
SEC EDGARForm 4 filed Mar 8, 2024